Puma Biotechnology, Inc.PBYINASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+39.2%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+39.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.7x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$59.01M+22.8%
2024$48.08M+1.2%
2023$47.52M+117.1%
2022$21.89M+566.7%
2021$-4.69M+86.9%
2020$-35.71M+31.9%
2019$-52.45M+44.9%
2018$-95.21M+67.0%
2017$-288.42M-4.7%
2016$-275.45M-